Next Article in Journal
Protection and Safety Evaluation of Live Constructions Derived from the Pgm and pPCP1 Yersinia pestis Strain
Previous Article in Journal
Clinical Challenges in a 49-Year-Old Patient with Severe Tick-Borne Myeloradiculitis Despite Complete Active Vaccination
Previous Article in Special Issue
Yellow Fever Virus Genotyping Tool and Investigation of Suspected Adverse Events Following Yellow Fever Vaccination
Correction to Vaccines 2019, 7(3), 72.
Correction

Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72

1
The Jenner Institute, Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), University of Oxford, Oxford OX1 2JD, UK
2
Immunology, RIA, Inselspital, University of Bern, 3010 Bern, Switzerland
3
Artemis Bio-Support, Molengraaffsingel, 2629 Delft, The Netherlands
4
Department of Chemistry and Biochemistry, University of Bern, 3010 Bern, Switzerland
5
Bencard Adjuvant Systems, Worthing BN14 8SA, UK
6
Department of Viroscience, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands
*
Authors to whom correspondence should be addressed.
Vaccines 2020, 8(1), 94; https://doi.org/10.3390/vaccines8010094
Received: 13 February 2020 / Accepted: 19 February 2020 / Published: 20 February 2020
Note: In lieu of an abstract, this is an excerpt from the first page.

The authors wish to make the following correction to their paper [...] View Full-Text
Show Figures

Figure 2

MDPI and ACS Style

Cabral-Miranda, G.; Lim, S.M.; Mohsen, M.O.; Pobelov, I.V.; Roesti, E.S.; Heath, M.D.; Skinner, M.A.; Kramer, M.F.; Martina, B.E.E.; Bachmann, M.F. Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72. Vaccines 2020, 8, 94. https://doi.org/10.3390/vaccines8010094

AMA Style

Cabral-Miranda G, Lim SM, Mohsen MO, Pobelov IV, Roesti ES, Heath MD, Skinner MA, Kramer MF, Martina BEE, Bachmann MF. Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72. Vaccines. 2020; 8(1):94. https://doi.org/10.3390/vaccines8010094

Chicago/Turabian Style

Cabral-Miranda, Gustavo, Stephanie M. Lim, Mona O. Mohsen, Ilya V. Pobelov, Elisa S. Roesti, Matthew D. Heath, Murray A. Skinner, Matthias F. Kramer, Byron E.E. Martina, and Martin F. Bachmann. 2020. "Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72" Vaccines 8, no. 1: 94. https://doi.org/10.3390/vaccines8010094

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop